{"id":"https://openalex.org/W4362476828","doi":"https://doi.org/10.1158/1535-7163.c.6536824.v1","title":"Data from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma","display_name":"Data from Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362476828","doi":"https://doi.org/10.1158/1535-7163.c.6536824.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.c.6536824.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536824.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6536824.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://dx.doi.org/10.1158/1535-7163.c.6536824.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083655413","display_name":"Diana D. Cirstea","orcid":"https://orcid.org/0000-0002-5719-581X","observed_orcids":["https://orcid.org/0000-0002-5719-581X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Cirstea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Loredana Santo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Loredana Santo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091207345","display_name":"Teru Hideshima","orcid":"https://orcid.org/0000-0003-2939-6224","observed_orcids":["https://orcid.org/0000-0003-2939-6224"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Teru Hideshima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017884571","display_name":"Homare Eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Homare Eda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031782171","display_name":"Yuko Matsumoto Mishima","orcid":"https://orcid.org/0000-0002-9742-8470","observed_orcids":["https://orcid.org/0000-0002-9742-8470"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yuko Mishima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059621897","display_name":"Neeharika Nemani","orcid":"https://orcid.org/0000-0002-2012-4639","observed_orcids":["https://orcid.org/0000-0002-2012-4639"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Neeharika Nemani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022060032","display_name":"Anuj Kumar Mahindra","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anuj Mahindra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055089118","display_name":"Andrew Jenho Yee","orcid":"https://orcid.org/0000-0003-3623-7491","observed_orcids":["https://orcid.org/0000-0003-3623-7491"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrew Yee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049134468","display_name":"G\u00fcll\u00fc G\u00f6rg\u00fcn","orcid":"https://orcid.org/0000-0001-9875-8394","observed_orcids":["https://orcid.org/0000-0001-9875-8394"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gullu Gorgun","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039965800","display_name":"Yiguo Hu","orcid":"https://orcid.org/0000-0002-3973-2140","observed_orcids":["https://orcid.org/0000-0002-3973-2140"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yiguo Hu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040386659","display_name":"Hiroto Ohguchi","orcid":"https://orcid.org/0000-0001-8461-7398","observed_orcids":["https://orcid.org/0000-0001-8461-7398"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hiroto Ohguchi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039444594","display_name":"Rikio Suzuki","orcid":"https://orcid.org/0000-0002-2841-6230","observed_orcids":["https://orcid.org/0000-0002-2841-6230"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rikio Suzuki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034020009","display_name":"Francesca Cottini","orcid":"https://orcid.org/0000-0001-8676-7840","observed_orcids":["https://orcid.org/0000-0001-8676-7840"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesca Cottini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040373927","display_name":"Sylvie Mireille Guichard","orcid":"https://orcid.org/0000-0003-1143-2805","observed_orcids":["https://orcid.org/0000-0003-1143-2805"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sylvie M. Guichard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5052048627","display_name":"Noopur S Raje","orcid":"https://orcid.org/0000-0003-3066-1275","observed_orcids":["https://orcid.org/0000-0003-3066-1275"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Noopur Raje","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9154999852180481,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.08179999887943268,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11501","display_name":"TGF-\u03b2 signaling in diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9190000295639038},{"id":"https://openalex.org/keywords/mtor-inhibitors","display_name":"mTOR inhibitors","score":0.7419999837875366},{"id":"https://openalex.org/keywords/azd8055","display_name":"AZD8055","score":0.9909999966621399},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.8190000057220459},{"id":"https://openalex.org/keywords/torc1","display_name":"TORC1","score":0.6990000009536743},{"id":"https://openalex.org/keywords/torc2","display_name":"TORC2","score":0.902999997138977},{"id":"https://openalex.org/keywords/igf-1-receptor","display_name":"IGF-1 receptor","score":0.8040000200271606},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.7990000247955322},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9549999833106995},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.7990000247955322},{"id":"https://openalex.org/keywords/bone-marrow-stroma","display_name":"bone marrow stroma","score":0.8080000281333923},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7799999713897705}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7725439071655273},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.7065367698669434},{"id":"https://openalex.org/C107846503","wikidata":"https://www.wikidata.org/wiki/Q14876061","display_name":"mTORC2","level":5,"score":0.7052912712097168},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.7045853137969971},{"id":"https://openalex.org/C127561419","wikidata":"https://www.wikidata.org/wiki/Q224527","display_name":"Downregulation and upregulation","level":3,"score":0.550453245639801},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.44639572501182556},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4285832345485687},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.3663322329521179},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3214260935783386},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17426148056983948},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14713746309280396},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1535-7163.c.6536824.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536824.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6536824.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.c.6536824.v1","doi":"https://doi.org/10.1158/1535-7163.c.6536824.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.c.6536824.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2105721960","https://openalex.org/W7095820694","https://openalex.org/W2580458132","https://openalex.org/W2591503573","https://openalex.org/W2979294245","https://openalex.org/W7099972936","https://openalex.org/W2054420941","https://openalex.org/W7154494409","https://openalex.org/W2552716711","https://openalex.org/W2573768216"],"abstract_inverted_index":{"Abstract":[0],"Despite":[1],"promising":[2,189],"preclinical":[3],"results":[4],"with":[5,104,182,194],"mTOR":[6,43,58,80,155],"kinase":[7,59,156],"inhibitors":[8],"in":[9,51,72,76,96,102,116,130,168,191],"multiple":[10,40,52,73,97,119,133,149,192],"myeloma,":[11],"resistance":[12],"to":[13,142],"these":[14],"drugs":[15],"may":[16],"arise":[17],"via":[18,82],"feedback":[19,44],"activation":[20],"loops.":[21],"This":[22],"concern":[23],"is":[24,37,187],"especially":[25],"true":[26],"for":[27,69],"insulin-like":[28],"growth":[29,110],"factor":[30],"1":[31],"receptor":[32],"(IGF1R),":[33],"because":[34],"IGF1R":[35,128,165],"signaling":[36],"downregulated":[38],"by":[39],"AKT":[41],"and":[42,93,109,147,158,172,184],"mechanisms.":[45],"We":[46,62,86],"have":[47],"tested":[48],"this":[49,170],"hypothesis":[50],"myeloma":[53,74,98,120,134,150,193],"using":[54],"the":[55,67,77],"novel":[56],"selective":[57],"inhibitor":[60],"AZD8055.":[61],"evaluated":[63],"p-mTOR":[64],"S2481":[65],"as":[66],"readout":[68],"mTORC2/Akt":[70],"activity":[71],"cells":[75,99,108,141,151],"context":[78],"of":[79,91,118,127,139,163],"inhibition":[81,90,157],"AZD8055":[83,89,114,122,183],"or":[84,101],"rapamycin.":[85],"next":[87],"validated":[88],"mTORC1":[92],"mTORC2":[94],"functions":[95],"alone":[100],"culture":[103],"bone":[105],"marrow":[106],"stroma":[107],"factors.":[111],"Unlike":[112],"rapamycin,":[113],"resulted":[115,167],"apoptosis":[117,153],"cells.":[121],"treatment,":[123],"however,":[124],"induced":[125,144],"upregulation":[126],"phosphorylation":[129],"p-Akt":[131,145],"S473\u2013expressing":[132],"cell":[135],"lines.":[136],"Furthermore,":[137],"exposure":[138],"AZD8055-treated":[140],"IGF1":[143],"S473":[146],"rescued":[148],"from":[152],"despite":[154],"TORC2/Akt":[159],"blockage.":[160],"The":[161],"addition":[162],"blocking":[164],"antibody":[166],"reversing":[169],"effect":[171],"increased":[173],"AZD8055-induced":[174],"apoptosis.":[175],"Our":[176],"study":[177],"suggests":[178],"that":[179],"combination":[180],"treatment":[181],"IGF1R-blocking":[185],"agents":[186],"a":[188],"strategy":[190],"potential":[195],"IGF1R/Akt":[196],"signaling\u2013mediated":[197],"survival.":[198],"Mol":[199],"Cancer":[200],"Ther;":[201],"13(11);":[202],"2489\u2013500.":[203],"\u00a92014":[204],"AACR.":[205]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-05T00:00:00"}